Headquartered in Copenhagen, with offices in San Francisco, Boston, London, Singapore and Shanghai, Novo Holdings manages the operating and financial assets of the Novo Nordisk Foundation.
The purpose of Novo Holding is one with that of the Novo Nordisk Foundation, which is to Improve People’s Health and the Sustainability of Society and the Planet.
Novo Holdings is a holding and investment company that is responsible for managing the assets of the Novo Nordisk Foundation, one of the world’s largest enterprise foundations.
Novo Holdings is the controlling shareholder of Novo Nordisk and Novozymes and manages an investment portfolio, with a long-term return perspective. Novo Holdings is a world leading investor in the life sciences and also manages a broad portfolio of equities, bonds, real estate and infrastructure assets as well as private equity investments.
As of year-end 2021, Novo Holdings had total assets of USD 106 billion. For more information, download our fact sheet.
Our collegues aspire to be leading responsible investors, recognised for delivering strong financial returns and positive societal impact.
We aspire to become catalysts of change by investing in companies that – like Novo Holdings – believe that there are achievable solutions to the pressing challenges facing both humankind and our planet. Read more.
Total investment assets of Novo Holdings at the end of 2021.
Return on Life Science investments last 5 years.
Return on Capital investments last 5 years.
Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
Denmark
+45 3527 6500
CVR# 24257630
Novo Ventures (US) Inc.*
200 Clarendon Street, Floor 45
Boston, MA 02116
USA
Novo Ventures (US) Inc.*
501 2nd Street, Suite 300
San Francisco, CA 94107
USA
+1 (415) 552-6686
Novo Holdings Equity Asia Pte. Ltd.*
6 Battery Road #23-03
Singapore 049909
Singapore
Novo Holdings Equity US Inc.*
501 2nd Street, Suite 300
San Francisco, CA 94107
USA
+1 (415) 552-6686
Novo Holdings Equity US Inc.*
200 Clarendon Street, Floor 45
Boston, MA 02116
USA
Media Relations
Christian Mostrup Scheel
Senior Press Officer
cims@novo.dk
+45 3067 4805
*Novo Ventures (US) Inc., Novo Holdings Equity US Inc., comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. Ltd. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.